CytoReason expands deal with Sanofi to look at IBD
CytoReason, which creates computational disease modeling, has announced an expansion of its collaboration with Sanofi.…
CytoReason, which creates computational disease modeling, has announced an expansion of its collaboration with Sanofi.…
The guests on our podcast this week are: Jessica Robinson, project director, Advanced Therapies Congress,…
Aldevron, which develops and manufactures plasmid DNA, RNA and proteins for the biotech industry, has…
By Brittany Niccum and Han Wei Now that we are past the holiday season and…
Glioblastoma (GBM) is a WHO grade IV brain tumor with dismal prognosis. Although post-surgical radiation…
DeuterOncology, a clinical-stage drug development company, has closed €5.65 million ($6.1 million) series A financing,…
Brenus Pharma and InSphero AG have received a €1.5 million grant for the collaborative project…
Proscia, a provider of digital and computational pathology solutions, has announced that the Netherlands Cancer…
Cambridge U.K. biotech company SolasCure, which is developing a wound cleaning technology, has published its…
Avacta Group plc says that AVA6000 continues to show a favorable safety profile in the…
GPCR Therapeutics, Inc., a drug discovery company targeting G Protein Coupled Receptors (GPCR) pairs, has…
Pathalys Pharma, Inc. and Launch Therapeutics (Launch Tx) have announced a collaboration to advance phase…